Alpine Global Management, LLC - XERIS BIOPHARMA HOLDINGS INC ownership

XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 111 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.

Quarter-by-quarter ownership
Alpine Global Management, LLC ownership history of XERIS BIOPHARMA HOLDINGS INC
ValueSharesWeighting
Q3 2023$558,000
-5.3%
300,000
+33.3%
0.14%
-21.2%
Q2 2023$589,500
-9.6%
225,000
-43.8%
0.18%
-29.2%
Q1 2023$652,000
+122456.4%
400,0000.0%0.25%
+42.9%
Q4 2022$532
-99.9%
400,0000.0%0.18%
+21.2%
Q3 2022$624,000
+15.8%
400,000
+14.3%
0.15%
+7.4%
Q2 2022$539,000
-66.7%
350,000
-44.7%
0.14%
-32.3%
Q1 2022$1,620,000
+87.5%
633,040
+114.6%
0.20%
+58.3%
Q4 2021$864,000295,0000.13%
Other shareholders
XERIS BIOPHARMA HOLDINGS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 6,039,028$9,843,61624.86%
Stonepine Capital Management, LLC 8,640,205$14,083,5344.72%
Alpine Global Management, LLC 400,000$652,0000.25%
DELTEC ASSET MANAGEMENT LLC 622,072$1,013,9770.25%
XTX Topco Ltd 233,385$380,4180.08%
Redmile Group, LLC 1,046,587$1,705,9370.07%
GSA CAPITAL PARTNERS LLP 316,025$5150.05%
Yakira Capital Management, Inc. 90,076$146,8240.04%
IHT Wealth Management, LLC 281,442$458,7620.03%
TUDOR INVESTMENT CORP ET AL 960,111$1,5650.02%
View complete list of XERIS BIOPHARMA HOLDINGS INC shareholders